| This article has been cited by |
| 1 | A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis | |
| Jane R. Schwebke,Franklin G. Morgan,William Koltun,Paul Nyirjesy |
| American Journal of Obstetrics and Gynecology.2017;217(6)678.e1 |
| [DOI] |
|
| 2 | Characterization and Treatment of Recurrent Bacterial Vaginosis | |
| Brooke M. Faught,Sonia Reyes |
| Journal of Women's Health.2019;28(9)1218 |
| [DOI] |
|
| 3 | Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment | |
| Paul Nyirjesy,Jane R Schwebke |
| Future Microbiology.2018;13(5)507 |
| [DOI] |
|
| 4 | Combined vaginal administration of nystatin, diiodohydroxyquin, and benzalkonium chloride versus oral metronidazole for the treatment of bacterial vaginosis | |
| Wichinee Chooprasertsuk,Woraluk Somboonporn,Sukree Soontrapa,LingLing Salang,Siriruthai Amnatbuddee |
| International Journal of Gynecology & Obstetrics.2019;145(3)261 |
| [DOI] |
|
| 5 | Combined vaginal administration of nystatin, diiodohydroxyquin, and benzalkonium chloride versus oral metronidazole for the treatment of bacterial vaginosis | |
| Scott Worswick,Sean Dreyer |
| International Journal of Gynecology & Obstetrics.2018;145(3)471 |
| [DOI] |
|
| 6 | In situ reactivity of electrochemically generated nitro radical anion on Ornidazole and its monomeric Cu(II) complex with nucleic acid bases and calf thymus DNA | |
| Promita Nandy,Saurabh Das |
| Inorganica Chimica Acta.2020;501(3)119267 |
| [DOI] |
|
| 7 | Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients | |
| Ashwini Kamble,Shilpa Naik,Manju Talathi,Deepali Jadhav,Samradni Pingale,Ruchika Kaul-Ghanekar |
| Archives of Microbiology.2022;204(8)119267 |
| [DOI] |
|
| 8 | New principles of treatment of vaginal dysbiosis in reproductive aged wom?n | |
| ?. ?. ?????????,?. ?. ????????? |
| Reproductive Endocrinology.2019;0(49)62 |
| [DOI] |
|
| 9 | In Vivo Inhibitory Assessment of Potential Antifungal Agents on Nosema ceranae Proliferation in Honey Bees | |
| Rassol Bahreini,Medhat Nasr,Cassandra Docherty,Olivia de Herdt,David Feindel,Samantha Muirhead |
| Pathogens.2022;11(11)1375 |
| [DOI] |
|
| 10 | Comparative Effectiveness of Treatments for Bacterial Vaginosis: A Network Meta-Analysis | |
| Alison Muñoz-Barreno,Fausto Cabezas-Mera,Eduardo Tejera,António Machado |
| Antibiotics.2021;10(8)978 |
| [DOI] |
|
| 11 | A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2?g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis | |
| Steven E. Chavoustie,Janet K. Gersten,Milroy J. Samuel,Jane R. Schwebke |
| Journal of Women's Health.2018;27(4)492 |
| [DOI] |
|
| 12 | Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions | |
| Daniela Machado,Joana Castro,Ana Palmeira-de-Oliveira,José Martinez-de-Oliveira,Nuno Cerca |
| Frontiers in Microbiology.2016;6(4)492 |
| [DOI] |
|
| 13 | Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin | |
| Melinda A.B. Petrina,Lisa A. Cosentino,Lorna K. Rabe,Sharon L. Hillier |
| Anaerobe.2017;47(4)115 |
| [DOI] |
|
| 14 | Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis | |
| Shrouk M. Elghazaly,Khaled M. Hamam,Marwa M. Badawy,Nadim Aiman Yakoub Agha,Ahmed Samy,Ahmed M. Abbas |
| European Journal of Obstetrics & Gynecology and Reproductive Biology.2019;238(4)125 |
| [DOI] |
|
| 15 | Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it's associated resistance patterns | |
| Ayesha Javed,Fahed Parvaiz,Sobia Manzoor |
| Microbial Pathogenesis.2019;127(4)21 |
| [DOI] |
|
| 16 | Short courses of antimicrobial therapy for bacterial vaginosis: the possibilities of modern pharmacology: A review | |
| Evgenia V. Shikh,Natalia B. Lazareva,Tatyana M. Ponomarenko |
| Gynecology.2022;24(4)271 |
| [DOI] |
|
| 17 | Secnidazole for treatment of bacterial vaginosis: a systematic review | |
| Mohamed A. Abd El Aziz,Foruzan Sharifipour,Parvin Abedi,Shayesteh Jahanfar,Helen Marie Judge |
| BMC Women's Health.2019;19(1)271 |
| [DOI] |
|
| 18 | Bacterial Vaginosis: What Do We Currently Know? | |
| Linda Abou Chacra,Florence Fenollar,Khoudia Diop |
| Frontiers in Cellular and Infection Microbiology.2022;11(1)271 |
| [DOI] |
|
| 19 | Gardnerella and vaginal health: the truth is out there | |
| Aliona S Rosca,Joana Castro,Lúcia G V Sousa,Nuno Cerca |
| FEMS Microbiology Reviews.2020;44(1)73 |
| [DOI] |
|
| 20 | Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections | |
| Roberta Gaziano,Samuele Sabbatini,Elena Roselletti,Stefano Perito,Claudia Monari |
| Frontiers in Microbiology.2020;11(1)73 |
| [DOI] |
|
